LIA
BNTX icon

Limestone Investment Advisors’s BioNTech BNTX Stock Holding History

Limestone Investment Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Hold
17,190
– – 0.12% 144
2026
Q1 		$1.53M Hold
17,190
– – 0.12% 124
2025
Q4 		$1.64M Hold
17,190
– – 0.16% 109
2025
Q3 		$1.7M Hold
17,190
– – 0.13% 131
2025
Q2 		$1.83M Buy
+17,190
New +$1.74M 0.16% 123

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Limestone Investment Advisors's BNTX Position: Q2 2026 in Review

Limestone Investment Advisors held its BioNTech (BNTX) position steady in Q2 2026 at 17,190 shares worth $1.6M. The position accounts for 0.12% of the portfolio, ranked #144.

Limestone Investment Advisors first reported a position in BNTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.83M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Limestone Investment Advisors held 17,190 shares of BioNTech worth $1.6M as of Q2 2026.
  • Limestone Investment Advisors left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up 0.12% of Limestone Investment Advisors's portfolio in Q2 2026, its #144 holding.
  • Limestone Investment Advisors first reported a position in BioNTech in Q2 2025 and has held it in 5 quarters since.
  • Limestone Investment Advisors's BioNTech position peaked at $1.83M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Limestone Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.